Glandubolin en es it fr

Glandubolin Brand names, Glandubolin Analogs

Glandubolin Brand Names Mixture

  • Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
  • Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)

Glandubolin Chemical_Formula


Glandubolin RX_link

No information avaliable

Glandubolin fda sheet

Glandubolin msds (material safety sheet)

Glandubolin MSDS

Glandubolin Synthesis Reference

G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)

Glandubolin Molecular Weight

270.366 g/mol

Glandubolin Melting Point

254.5-256 oC

Glandubolin H2O Solubility

3 g/100mL

Glandubolin State


Glandubolin LogP


Glandubolin Dosage Forms

Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension

Glandubolin Indication

For management of Menopausal and postmenopausal disorders

Glandubolin Pharmacology

Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.

Glandubolin Absorption


Glandubolin side effects and Toxicity

Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.

Glandubolin Patient Information

Glandubolin Organisms Affected

Humans and other mammals